SCHEDULE 13G/A: BlackRock Discloses 6.4% Passive Stake in Oscar Health

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.4% passive beneficial ownership stake in Oscar Health, Inc. as of June 30, 2025.

Summary

• BlackRock, Inc. reported beneficial ownership of 13,941,711 shares of Oscar Health, Inc. Class A Stock.
• This represents 6.4% of the total outstanding Class A Stock.
• BlackRock holds sole voting power over 13,635,493 shares and sole dispositive power over 13,941,711 shares.
• The filing is an Amendment No. 2 to a Schedule 13G, indicating a change in beneficial ownership or reporting status.
• BlackRock certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Oscar Health, Inc.
• Several BlackRock subsidiaries are identified as having beneficial ownership, with BlackRock Investment Management, LLC specifically noted as owning 5% or greater of the outstanding shares.

Sentiment

Score: 7

Explanation: The filing indicates a significant, passive institutional investment by BlackRock, which is generally a positive signal of confidence in the company's long-term prospects, without implying any activist intent or immediate operational changes.

Positives

• BlackRock, a major institutional investor, holds a significant passive stake, which can be interpreted as a vote of confidence in Oscar Health's long-term prospects without implying activist intent.
• The filing explicitly states that BlackRock's investment is for ordinary course of business, not for the purpose of influencing control, which provides clarity on their investment strategy.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding Oscar Health, Inc.'s future performance or BlackRock's investment strategy beyond the passive nature of the holding.

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

Industry Context

This filing indicates a significant passive investment by a major asset manager in the healthcare technology and insurance sector, reflecting ongoing institutional interest in companies like Oscar Health. It highlights the continued presence of large institutional investors in the health tech space.

Comparison to Industry Standards

• This filing is a standard disclosure of beneficial ownership by a passive institutional investor, consistent with SEC regulations for Schedule 13G filers.
• It does not contain performance metrics or operational results that would allow for a direct comparison to industry standards or specific comparable companies/projects.
• The 6.4% stake represents a notable holding for a single institutional investor in a publicly traded company within the healthcare technology sector.

Stakeholder Impact

• Shareholders: Increased institutional ownership by a major asset manager may be viewed positively, potentially signaling long-term confidence in the company.
• Management: The passive nature of the investment indicates no immediate pressure for strategic or operational changes from BlackRock.

Key Dates

Recommendation

Keywords

Oscar Health, BlackRock, Schedule 13G, Beneficial Ownership, Class A Stock, Institutional Investment, Healthcare Technology, Health Insurance